Genome evolution during progression to breast cancer

Genome Research

Volumn 23, Issue 7, 2013, Pages 1097-1108

  Newburger, Daniel E ^a   Kashef Haghighi, Dorna ^b   Weng, Ziming ^a   Salari, Raheleh ^b   Sweeney, Robert T ^a   Brunner, Alayne L ^a   Zhu, Shirley X ^a   Guo, Xiangqian ^a   Varma, Sushama ^a   Troxell, Megan L ^c   West, Robert B ^a   Batzoglou, Serafim ^b   Sidow, Arend ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; DNA;

ANEUPLOIDY; ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER PATIENT; CANCER TISSUE; CARCINOMA IN SITU; CELL DIVISION; CELL LINEAGE; CLINICAL ARTICLE; DISEASE COURSE; EVOLUTION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANEUPLOIDY; BREAST NEOPLASMS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880056229     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.151670.112     Document Type: Article

References (45)

1. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO. 2007. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 31: 417-426.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
3. Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, et al. 2012. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486: 405-409.
4. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, et al. 2010. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
5. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, Buck G, Chen L, Beare D, Latimer C, et al. 2010. Signatures of mutation and selection in the cancer genome. Nature 463: 893-898.
6. Bombonati A, Sgroi DC. 2011. The molecular pathology of breast cancer progression. J Pathol 223: 307-317.
7. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, et al. 2011. Initial genome sequencing and analysis of multiple myeloma. Nature 471: 467-472.
8. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. 2012. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482: 53-58.
9. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et al. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486: 346-352.
10. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. 2011. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
11. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, et al. 2010. Genome remodelling in a basallike breast cancer metastasis and xenograft. Nature 464: 999-1005.
12. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, et al. 2012. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481: 506-510.
13. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, et al. 2012. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486: 353-360.
14. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, et al. 2012. Intratumor heterogeneity and branched evolution revealed by Multiregion sequencing. N Engl J Med 366: 883-892.
15. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. 2007. Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
16. Huang DW, Sherman BT, Lempicki RA. 2009. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
17. Hwang DG, Green P. 2004. Bayesian Markov chain Monte Carlo sequence analysis reveals varying neutral substitution patterns in mammalian evolution. Proc Natl Acad Sci 101: 13994-14001.
18. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, et al. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488: 471-475.
19. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjöblom T, Park BH, Parsons R, et al. 2008. Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci 105: 16224-16229.
20. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, et al. 2008. DNA sequencing of a cytogenetically normal acutemyeloid leukaemia genome. Nature 456: 66-72.
21. Liu P, Erez A, Nagamani SC, Dhar SU, Kolodziejska KE, Dharmadhikari AV, Cooper ML, Wiszniewska J, Zhang F, Withers MA, et al. 2011. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell 146: 889-903.
22. Lopez-Garcia MA, Geyer FC, Lacroix-TrikiM,Marchió C, Reis-Filho JS. 2010. Breast cancer precursors revisited: Molecular features and progression pathways. Histopathology 57: 171-192.
23. Maher CA, Wilson RK. 2012. Chromothripsis and human disease: Piecing together the shattering process. Cell 148: 29-32.
24. Mardis ER. 2012. Genome sequencing and cancer. Curr Opin Genet Dev 22: 245-250.
25. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. 2010. The Genome Analysis Toolkit: A MapReduce framework for analyzing nextgeneration DNA sequencing data. Genome Res 20: 1297-1303.
26. Meyerson M, Pellman D. 2011. Cancer genomes evolve by pulverizing single chromosomes. Cell 144: 9-10.
27. Mills RE, Luttig CT, Larkins CE, BeauchampA, Tsui C, Pittard WS, Devine SE. 2006. An initial map of insertion and deletion (INDEL) variation in the human genome. Genome Res 16: 1182-1190.
28. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. 2011. Tumour evolution inferred by single-cell sequencing. Nature 472: 90-94.
29. Nik-Zainal S, Alexandrov LB,Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, et al. 2012a. Mutational processes molding the genomes of 21 breast cancers. Cell 149: 979-993.
30. Nik-Zainal S, Van Loo P,Wedge DC, Alexandrov LB, Greenman CD, LauKW, Raine K, Jones D, Marshall J, Ramakrishna M, et al. 2012b. The life history of 21 breast cancers. Cell 149: 994-1007.
31. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, et al. 2010a. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
32. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, et al. 2010b. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
33. Samuels Y,Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, et al. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554.
34. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J, et al. 2009. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813.
35. Shah SP, Roth A, Goya R,Oloumi A, Ha G, Zhao Y, Turashvili G, Ding J, Tse K, Haffari G, et al. 2012. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395-399.
36. Simpson PT,Gale T, Reis-Filho JS, JonesC, Parry S, Sloane JP,Hanby A, Pinder SE, Lee AH, Humphreys S, et al. 2005. Columnar cell lesions of the breast: The missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29: 734-746.
37. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144: 27-40.
38. Stratton MR. 2011. Exploring the genomes of cancer cells: Progress and promise. Science 331: 1553-1558.
39. StrattonMR, Campbell PJ, Futreal PA. 2009. The cancer genome. Nature 458: 719-724.
40. Sved J, Bird A. 1990. The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci 87: 4692-4696.
41. Troxell ML, Brunner AL, Neff T,Warrick A, Beadling C, Montgomery K, Zhu S, Corless CL, West RB. 2012. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Pathol 25: 930-937.
42. Turajlic S, Furney SJ, Lambros MB, Mitsopoulos C, Kozarewa I, Geyer FC, MacKay A, Hakas J, Zvelebil M, Lord CJ, et al. 2012. Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res 22: 196-207.
43. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, Larson DE, McLellan MD, Dooling D, Abbott R, et al. 2012. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 366: 1090-1098.
44. Wu X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ,Witt H, Croul S, Bouffet E, Fults DW, Eberhart CG, et al. 2012. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482: 529-533.
45. Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, KamiyamaM, Hruban RH, Eshleman JR, Nowak MA, et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.